Clinical approach to clinical herbal toxicity

Seminars in Diagnostic Pathology

Volumn 26, Issue 1, 2009, Pages 28-37

  Tovar, Richard T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Germander; Herbal agents; Kava kava; Licorice

Indexed keywords

ACONITUM EXTRACT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA TOCOPHEROL; ANDROSTENEDIONE; ARISTOLOCHIC ACID; CANTHARIDIN; COMFREY EXTRACT; CYCLOSPORIN; DIGOXIN; EPHEDRINE; EUCALYPTUS EXTRACT; GARLIC EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; KAVA; NOPAL; PAROXETINE; PEPPERMINT; PYRIDOXINE; PYRROLIZIDINE ALKALOID; STRAMONIUM; UNINDEXED DRUG; VALERIAN; WARFARIN;

ALLERGY; ANGELICA SINENSIS; ANOREXIA; ANTHRAX; AROMATHERAPY; ARTICLE; ASIAN GINSENG; ATAXIA; ATROPHY; AYURVEDA; BLEEDING; BLOOD TOXICITY; BLURRED VISION; BRAIN DISEASE; BRAIN VASCULITIS; CARDIOTOXICITY; CAULOPHYLLUM; CHAN SU; CHAPARRAL; CHEST TIGHTNESS; CHINESE MEDICINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMA; COMFREY; CONFUSION; COUGHING; CYANOSIS; DEATH; DELIRIUM; DIARRHEA; DIZZINESS; DROWSINESS; DYSPNEA; ECCHYMOSIS; ELECTROLYTE DISTURBANCE; ELEUTHEROCOCCUS SENTICOSUS; ENDOCRINE DISEASE; EPHEDRA; FATIGUE; FETAL HEMORRHAGE; FIBROSING ALVEOLITIS; GASTROINTESTINAL SYMPTOM; GERMANDER; GINSENG; GLYCYRRHIZA; HALLUCINATION; HANGOVER; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HEART VENTRICLE TACHYCARDIA; HEMATURIA; HEPATITIS; HERB; HERBAL MEDICINE; HISTORY; HOMEOPATHY; HUMAN; HYPERICUM PERFORATUM; HYPERTENSION; HYPERTHYROIDISM; HYPOGLYCEMIA; HYPOKALEMIA; HYPOTENSION; INSOMNIA; IRRITABILITY; JAUNDICE; KIDNEY DISEASE; KIDNEY TUBULE DAMAGE; LABORATORY TEST; LEUKOPENIA; LIVER DISEASE; LIVER TOXICITY; LU SHEN WAN; LUNG TOXICITY; MANIA; MASTALGIA; MITOCHONDRIAL DNA DEPLETION SYNDROME; NAUSEA; NEPHROTOXICITY; NONHUMAN; NUTMEG; ORGAN INJURY; PARALYSIS; PRIORITY JOURNAL; RESTLESSNESS; SALVIA MILTIORRHIZA; SAUROPUS ANDROGYNUS; SEAWEED; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SODIUM RETENTION; TOXIC HEPATITIS; TOXICITY; UNITED STATES; VISCUM ALBUM; VOMITING; WATER RETENTION; WEAKNESS; WEIGHT REDUCTION;

ANIMALS; FEMALE; HERB-DRUG INTERACTIONS; HERBAL MEDICINE; HUMANS; MATERNAL EXPOSURE; MEDICINE, TRADITIONAL; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 59249109340     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2008.12.004     Document Type: Article

References (86)

1. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States: 1990-1997: results of a follow-up national survey. JAMA 280 (1998) 1569-1575
2. http://www.fda.gov Accessed August 1, 2008
3. Dietary Supplement Health and Education Act of 1994, Publ. No. 103-417, Stat. 4325 (1994)
4. Bown D. The Herb Society of America New Encyclopedia of Herbs and Their Uses (2001), Dorling Kindersley, New York, NY 18
5. Bent S., and Ko R. Commonly used herbal medicines in the United States: a review. Am J Med 116 (2004) 478-485
6. Public Health Security and Bioterrorism Preparedness and Response Act of 2002, Publ. No. 107-188, 116, Stat. 594 (Jan. 23, 2002)
7. Pal S.K., and Yogeshwer S. Herbal medicine: current status and the future. Asian Pac J Cancer Prev 4 (2003) 281-288
8. Winslow L., and Kroll D. Herbs as medicines. Arch Intern Med 158 (1998) 2192-2211
9. Miller L. Herbal medicinals. Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158 (1998) 2200-2211
10. Woodward K. The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Hum Exp Toxicol 24 (2005) 219-233
11. Watkins R. Herbal therapeutics: the top 12 remedies. Emerg Med 34 (2002) 12-19
12. Milton D. Using alternative and complementary therapies in the emergency setting. J Emerg Nurs 24 (1998) 500-508
13. Moss T. Herbal medicine in the Emergency Department: a primer for toxicities and treatment. J Emerg Nurs 24 (1998) 509-513
14. Palmer M. Dietary supplements: "natural" is not always safe. Emerg Med 30 (1998) 52-74
15. Boyer E. Issues in the management of dietary supplement use among hospitalized patients. J Med Toxicol 1 (2005) 30-34
16. Woolf A.D., Watson W.A., Smolinske S., et al. The severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993-2002. Clin Toxicol 43 (2003) 347-355
17. Williamson E. Drug interactions between herbal and prescription medicines. Drug Safety 26 (2003) 1075-1092
18. Ernst E. Harmless herbs?. A review of the recent literature. Am J Med 104 (1998) 170-178
19. http://www.FDA.gov Accessed September 1, 2008
20. Saad B., Azaizeh H., Abu-Hijleh G., and Said O. Safety of traditional arab herbal medicine. Evid Based Complement Alternat Med 3 (2006) 433-439
21. Dasgupta A., and Bernard D.W. Herbal remedies. Effects on clinical laboratory tests. Arch Pathol Lab Med 130 (2006) 521-528
22. Dasgupta A., Biddle D.A., Wells A., et al. Positive and negative interference of Chinese medicine Chan Su in serum digoxin measurement: elimination of interference by using a monoclonal chemilunimescent digoxin assay or monitoring free digoxin concentration. Am J Clin Pathol 114 (2000) 174-179
23. Ko R.J. Safety of ethnic and imported herbal and dietary supplements. Clin Toxicol 44 (2006) 611-616
24. Huang W.F., Wen K.C., and Hsiao M.L. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 37 (1997) 344-350
25. Ko R.J. Adulterants in 260 Asian patent medicines. N Engl J Med 339 (1998) 847
26. Ko R.J. PC-SOES. Urology 61 (2003) 1292
27. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 52 (2003) 1361-1371
28. Koh H.L., and Woo S.O. Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs. Drug Safety 23 (2000) 351-362
29. Liang W.L., et al. Metal element analysis of commercial Chinese herbal medicines. Taiwan Kuxue 51 (1998) 37-56
30. Ueng T.H., et al. YaoShipin Fenxi 5 (1997) 241-263
31. Ernst E., and Pittler M.H. Risks associated with herbal medicine products. Wiener Medizinische Wochenschrift (2002) 183-189
32. Russo S., Mastropasqua M., Mosetti M.A., et al. Low dose of liquorice can induce hypertension encephalopathy. Am J Nephrol 20 (2000) 145-148
33. Ko R.J. Safety of ethnic and imported herbal and dietary supplements. Clin Toxicol 44 (2006) 611-616
34. Nambiar S., Schwartz R.H., Constantino A., et al. Hypertension in mother and baby linked to ingestion of Chinese herbal medicine. West J Med 171 (1999) 152
35. Jones T.K., and Lawson B.M. Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication. J Pediatr 132 (1998) 550-552
36. Ko R.J. A U.S. perspective on the adverse reactions from traditional Chinese medicines. J Chin Med Assoc 67 (2004) 109-116
37. Lin C.C., Chan T.Y., and Deng J.F. Clinical features and management of herbal induced Aconite poisoning. Ann Emerg Med 43 (2004) 574-579
38. Lin T.J., Lu C.C., Chen K.W., et al. Outbreak of obstructive ventilatory impairment associated with consumption of sauropus androgynus vegetable. Clin Toxicol 34 (1996) 1
39. Spyker D., Lore L.A., and Brooks S.M. An outbreak of pulmonary poisoning. Clin Toxicol 34 (1996) 15
40. Vanherweghem J.L., Depierreux M., Tielemans C., et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341 (1993) 387-391
41. Nortier J.L., Martinez M.C., Schmeiser H.H., et al. Urothelial carcinoma associated with the use of a Chinese herb (aristolochia fanchi). N Engl J Med 342 (2000) 1686-1692
42. Bent S., Goldberg H., Padula A., et al. Spontaneous bleeding associated with ginko biloba: a case report and systematic review of the literature. J Gen Intern Med 20 (2005) 657-661
43. Köhler S., Funk P., and Kieser M. Influence of a 7 day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo controlled double-blind study in health volunteers. Blood Coagul Fibrinolysis 15 (2004) 303-309
44. Haller C. Clinical approach to adverse effects and interactions related to herbal and dietary supplements. Clin Toxicol 44 (2006) 605-610
45. Corrigan J.J., et al. Coagulopathy associated with vitamin E ingestion. JAMA 230 (1974) 1300-1301
46. Heck A.M., DeWitt B.A., and Lukes A.L. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 57 (2000) 1221-1227
47. Escher M., Desmeules J., Giostra E., et al. Hepatitis associated with kava, a herbal remedy. Br J Med 322 (2001) 139
48. Gordon D.W., Rosenthal G., Hart J., et al. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA 273 (1995) 489-490
49. Laliberté L., and Villeneuve J.P. Hepatitis after use of Germander, a herbal remedy. CMAJ 154 (1996) 1689-1682
50. Harvey J., and Collin-Jones D.G. Mistletoe hepatitis. Br J Med (Clin Res Ed) 282 (1981) 186-187
51. Segelman A., Segelman F.P., Karliner J., et al. Sassafras and herb tea. Potential health hazards. J Am Med Assoc 236 (1976) 477
52. Kingston R.L., and Foley C. Herbal, traditional, and alternative medicines. In: Shannon M.W., Borron S.W., and Burns M. (Eds). Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. (ed 4) (2007), Elsevier Saunders 1077-1088
53. Roulet M., Laurini R., Rivier L., et al. Hepatic veno-occlusive disease in newborn infant of a women drinking herbal tea. J Pediatr 112 (1988) 433
54. Ridker P., Ohkuma S., McDermott W.V., et al. Hepatic veno-occlusive disease associated with the consumption of pyrrolizidine containing dietary substances. Gastroenterology 88 (1985) 1050
55. Teas J., Pino S., Critchley A., et al. Variability of iodine content in common commercially available edible seaweeds. Thyroid 14 (2004) 836-841
56. Marcus D., and Snodgrass W.R. Do no harm: avoidance of herbal medicines during pregnancy. Obset Gynecol 105 (2005) 1119-1122
57. Shilo S., and Hirsch H.J. Iodine induced hyperthyroidism in a patient with a normal thyroid gland. Postgrad Med J 62 (1986) 661-662
58. Shintani S., Marase H., Tsukagoshi H., et al. Glycyrrhizin (licorice) induced hypokalemic myopathy: report of 2 cases and review of the literature. Eur Neurol 32 (1992) 44-51
59. Maliakal P.P., and Wanwimolruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J Pharm Pharmacol 53 (2001) 1323-1329
60. Friedman J.M., and Teratology Society. presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy. Teratology 62 (2000) 134-137
61. Wilkinson J.M. Effect of Ginger tea on the fetal development of Sprague-Swaley rats. Reprod Toxicol 14 (2000) 507-512
62. Banerjee S., Sharma R., Kale R.K., et al. Influence of certain essential oils on carcinogen metabolizing enzymes and acid soluble sulfhydryls in mouse liver. Nutr Cancer 21 (1994) 263-269
63. Miyoshi N., Nakamura Y., Ueda Y., et al. Dietary ginger constituents, galanals A and B, are potent apoptosis in human T lymphoma Jurkat cells. Cancer Lett 199 (2003) 113-119
64. Backgon J. Ginger in preventing nausea and vomiting of pregnancy: a caveat due to its thromboxane synthetase activity and effect on testosterone binding. Eur J Obstet Gynecol Reprod Biol 42 (1991) 163-164
65. Kiuchi F., Iwakami S., Shibuya M., et al. Inhibition of prostaglandin and leukotriene synthesis by ginerols and diarylheptanoids. Chem Pharm Bull 40 (1992) 387-391
66. Heinrich M. Ethnobotony and natural products: the search for new molecules, new treatments of old diseases or a better understanding of indigenous cultures. Curr Top Med Chem 3 (2003) 141-154
67. Ernst E. Serious psychiatric and neurological adverse effects of herbal medicines: a systematic review. Acta Psychiatr Scand 108 (2003) 83-91
68. Saxe T. Toxicity of medicinal herbal preparations. Am Fam Phys 35 (1987) 135
69. Huang K. The Pharmacology of Chinese Herbs (1993), CRC Press, Boca Raton, FL
70. Centers for Disease Control and Prevention. Unexplained severe illness possibly associated with consumption with Kombucha tea-Iowa. MMWR 44 (1995) 892
71. Perron A., Patterson J.A., and Yanofsky N.N. Kombucha "mushroom" hepatotoxicity. Ann Emerg Med 26 (1995) 660
72. Mueller S.C., Majcher-Peszynska J., Uehleke B., et al. The extent of induction of CYP3A by St. John's Wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol 62 (2006) 29-36
73. Mathews J.M., Etheridge A.J., Black S.R., et al. Inhibition of human cytochrome P450 activities by Kava extract and kavalactones. Drug Metab Dispos 30 (2002) 1153-1157
74. Huang W.F., Wen K.C., Hsaio M.L., et al. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 37 (1997) 344-350
75. Haller C., Anderson I.B., Kim S.Y., et al. An evaluation of selected herbal reference texts and comparison to published reports of adverse herbal events. Adv Drug React Toxicol Rev 21 (2002) 143-150
76. Rodriguez-Fragoso L., Reyes-Esparza J., Burchiel S.W., et al. Risks and benefits of commonly used herbal medicines in Mexico. Toxicol Appl Pharmacol 227 (2008) 125-135
77. Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a review. J Intern Med 252 (2002) 107-113
78. Delgoda R., and Westlake A.C. Herbal interactions involving cytochrome P450 enzymes. Toxicol Rev 23 (2004) 239-249
79. Lazarou J. Incidence of adverse drug reactions in hospitalized patients: a meta analysis of prospective studies. J Am Med Asssoc 279 (1998) 1200-1205
80. World Health Organization. Traditional Medicine. [fact sheet no. 134] (2003), WHO, Geneva
81. Harnack L., Rydell S.A., and Stang J. Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn., metropolitan area. Mayo Clin Proc 76 (2001) 688-694
82. Eisenberg D. Unconventional medicine in the United States: prevalence, costs, and the patterns of use. N Engl J Med 328 (1993) 246-252
83. Bent S., and Ko R. Commonly used herbal medicines in the United States: a review. Am J Med 116 (2004) 478-485
84. Ruck B., Shih R.D., and Marcus S.M. Hypertensive crisis from herbal treatment of impotence. Am J Emerg Med 17 (1999) 317-318
85. Linden C., Vellman W.P., and Rumack B. Yohimbine: a new street drug. Ann Emerg Med 14 (1985) 1002-1004
86. Theoharides T.D. Sudden death of a healthy college student related to ephedrine toxicity from a Ma Huang containing drink. J Clin Psychopharmacol 17 (1997) 437-439